Stop HIV-1
This Phase 2 clinical trial investigated a new investigational treatment for HIV and was designed with two cohorts, each aimed at assessing different aspects of the intervention’s safety and efficacy. The study spanned 59 days and looked to recruit a total of 24 HIV-positive patients, aged 18 to 65, from both the United States and Latin America (LATAM). Participants were monitored closely throughout the trial, with regular assessments to evaluate viral load reduction, immune system response, and potential side effects. By recruiting a diverse patient population from two regions, the trial aimed to gather comprehensive data on the treatment's performance across different demographic groups, while also ensuring safety and effectiveness for a broad range of individuals living with HIV.
Skills:
• AI Generated Illustrations
• Custom Prompt
• Visual Design
• UI Design
• Creative/Art Direction
Solution:
For this HIV clinical trial, a dynamic, information-driven landing page was developed to streamline recruitment and improve participant engagement. The page featured an interactive site map with custom modules tailored to the study's inclusion criteria, allowing potential participants to quickly assess their eligibility. It also provided relevant, easily accessible study information, ensuring participants stayed informed about trial details directly related to their diagnosis. Along with recruitment materials, a variety of retention content—such as updates, educational resources, and motivational messages—was created for local sites to support ongoing participation. To resonate with the target audiences, AI-generated imagery was incorporated to bring a more inclusive representation of the various audiences that appealed to the diverse demographics.
